X
Xiaoqun Dong
H指数:39
被引数:3,719
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Corrigendum to “Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma” [Cancer Lett. 449 (2019) 87–98]
勘误:“靶向天冬氨酸β-羟化酶的抗体药物偶联物在胰腺导管腺癌中的抗肿瘤活性”[Cancer Lett. 449 (2019) 87–98]
Cancer Letters
IF10.1
Corrigendum to “ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma”[Cancer Lett. 611 (2025) 217396]
勘误:“ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma”[Cancer Lett. 611 (2025) 217396]
Cancer Letters
IF10.1
ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma
ASPH在肝细胞癌中调节细胞死亡并诱导化疗耐药
CANCER LETTERS
IF10.1
The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin
microRNA miR-181c通过下调骨桥蛋白增强乳腺癌细胞的化学敏感性并降低化学抗性

